TickerFacts.

Biodesix Inc (BDSX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$23.53M
Year ended 2025-12-31
-$20.24M
Trailing 12 months to 2026-06-30
2019-12-31: -$23.04M2020-12-31: -$23.31M2021-12-31: -$30.46M2022-12-31: -$48.27M2023-12-31: -$45.79M2024-12-31: -$51.88M2025-12-31: -$23.53M-$23.53M
2019-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$23.53Mn/m2026-02-26, From 2025-01-01
2024-12-31-$51.88Mn/m2026-02-26, From 2024-01-01
2023-12-31-$45.79Mn/m2025-03-03, From 2023-01-01
2022-12-31-$48.27Mn/m2024-03-01, From 2022-01-01
2021-12-31-$30.46Mn/m2023-03-06, From 2021-01-01
2020-12-31-$23.31Mn/m2022-03-14, From 2020-01-01
2019-12-31-$23.04Mn/a2021-03-16, From 2019-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Biodesix Inc (BDSX)2025-12-31-$23.53Mn/m
Personalis, Inc. (PSNL)2025-12-31-$79.45Mn/m
Exagen Inc. (XGN)2025-12-31-$14.27Mn/m
GRAIL, Inc. (GRAL)2025-12-31-$299.92Mn/m
American Shared Hospital Services (AMS)2025-12-31-$4.54Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$15.71Mn/m
Fulgent Genetics, Inc. (FLGT)2025-12-31-$124.21Mn/m
Castle Biosciences Inc (CSTL)2025-12-31$28.33M-22.5%
Veracyte, Inc. (VCYT)2025-12-31$126.63M+98.5%

Compare BDSX, PSNL, XGN, GRAL side by side · Screen every company in Services-Medical Laboratories ↗